Pay in 4 interest-free payments of $6.92 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Chronic injections of oxyntomodulin, which stimulates both glucagon and GLP-1 receptors, lower body weight among obese patients, and several oxyntomodulin analogs are being developed as a therapy for obesity
For best results, the company suggests pairing resM with daily exercise, a balanced diet emphasizing higher protein and fiber intake, and healthy sleep habits
Those are substantial numbers from dietary change alone
It was originally developed to treat type 2 diabetes but has gained popularity for its weight loss effects
It belongs to the class of drugs known as phosphodiesterase type 5 (PDE5) inhibitors, just like sildenafil
FDA Approval Status : Mounjaro: While Mounjaro is currently FDA-approved for Type 2 diabetes, its off-label use for weight loss is becoming increasingly popular
